LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

#EFIB2021: Industrial Biotechnology in the business spotlight for EU Green Deal

06/10/2021
PRESS RELEASE
Vienna, 6 October 2021 - Leading industry leaders, SMEs representatives, policy makers and academia are expected today in Vienna, Austria to join the 14th European Forum for Industrial Biotechnology and the Bioeconomy (EFIB). The annual event, hosted by EuropaBio, welcomes almost 350 participants to join discussions on industrial biotech innovations and future potential in fields such as food, feed & nutrition; sustainable materials; and bio-based industrial processes.

This year’s Conference, under the theme ‘Delivering the EU Green Deal: Industrial biotechnology into business’ will focus on how the sector can contribute to transforming the EU into a modern, resource-efficient and competitive economy.

’We are delighted that, after the Digital EFIB edition last year, we are able to invite participants to Vienna to discuss the contribution of industrial biotechnology in addressing societal and environmental challenges and realise its full potential in providing innovative solutions. We are celebrating the ability to do this in person, to meet, network and be together again’, says Dr Claire Skentelbery, Director General of EuropaBio.

EuropaBio is also proud to announce that an EFIB Vienna Statement - a vision document for Industrial Biotechnology will be launched at EFIB this year. An Executive Round table will finalise and present the Business vision for Europe from Industrial Biotechnology, setting yearly goals for policy and regulation to ensure that we can deliver Green Deal ambitions.

This year’s agenda will amongst +60 speakers will feature Anne Bogdanski, from Joint FAO/IAEA Centre and Kristin Schreiber Director, Directorate General for Internal Market, Industry and Entrepreneurship and SMEs, DG Grow, European Commission. Other speakers will include leading executives from companies such as Corbion, DSM, Cargill, Lenzing and others.

EFIB participants will also have the chance to meet with 20 local and international start-ups, learn about recent projects in the industrial biotechnology field at the dedicated poster presentation area and set up business meetings via EFIB Partnering tool.

EFIB delegates will have the opportunity to select the most influential advance from the industrial biotechnology and bioeconomy stories from the 25th EuropaBio anniversary programme. The winner will be announced in the EFIB Final plenary session, followed by the selection of the best Poster presentation at the Closing Session.

PRESS RELEASE - #EFIB2021: Industrial Biotechnology in the business spotlight for EU Green Deal


Download
Share
Communications Team
Communications Team

Related posts

30/09/2025

Public Consultation Response to the European Commission’s 28th Regime proposal


Read more
14/07/2025

EuropaBio Annual Report 2025


Read more
11/07/2025

Industrial Decarbonisation Accelerator Act – EuropaBio Position


Read more

Important links

  • Public Consultation Response to the European Commission’s 28th Regime proposal
  • EuropaBio Annual Report 2025

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.